Artia Global Partners LP Dyne Therapeutics, Inc. Transaction History
Artia Global Partners LP
- $517 Billion
- Q2 2024
A detailed history of Artia Global Partners LP transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Artia Global Partners LP holds 119,488 shares of DYN stock, worth $3.45 Million. This represents 0.82% of its overall portfolio holdings.
Number of Shares
119,488
Previous 119,488
-0.0%
Holding current value
$3.45 Million
Previous $3.39 Billion
24.3%
% of portfolio
0.82%
Previous 0.68%
Shares
1 transactions
Others Institutions Holding DYN
# of Institutions
203Shares Held
105MCall Options Held
82.7KPut Options Held
24.8K-
Atlas Venture Life Science Advisors, LLC8.02MShares$231 Million37.7% of portfolio
-
Fcpm Iii Services B.V. Naarden, P77.85MShares$226 Million40.83% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$213 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.39MShares$184 Million3.76% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$175 Million3.22% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.49B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...